X4 PHARMACEUTICALS INC's ticker is XFOR and the CUSIP is 98420X103. A total of 58 filers reported holding X4 PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $75 | -99.9% | 68 | -99.8% | 0.00% | – |
| Q2 2023 | $71,132 | – | 36,666 | +146564.0% | 0.00% | – |
| Q2 2021 | $0 | -100.0% | 25 | -97.7% | 0.00% | – |
| Q1 2021 | $9,000 | -52.6% | 1,068 | -64.7% | 0.00% | – |
| Q4 2020 | $19,000 | +280.0% | 3,023 | +291.1% | 0.00% | – |
| Q3 2020 | $5,000 | -75.0% | 773 | -63.3% | 0.00% | – |
| Q2 2020 | $20,000 | -35.5% | 2,104 | -33.1% | 0.00% | – |
| Q1 2020 | $31,000 | +24.0% | 3,144 | +32.2% | 0.00% | – |
| Q4 2019 | $25,000 | +257.1% | 2,379 | +304.6% | 0.00% | – |
| Q3 2019 | $7,000 | -75.9% | 588 | -69.9% | 0.00% | – |
| Q2 2019 | $29,000 | +383.3% | 1,955 | +398.7% | 0.00% | – |
| Q1 2019 | $6,000 | – | 392 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 6,247,500 | $6,809,775 | 2.18% |
| Bain Capital Life Sciences Investors, LLC | 15,960,588 | $17,397,041 | 1.94% |
| Stonepine Capital Management, LLC | 5,273,685 | $5,748,317 | 1.91% |
| NEA Management Company, LLC | 14,986,793 | $16,335,604 | 1.26% |
| Sio Capital Management, LLC | 2,599,003 | $2,832,913 | 0.88% |
| New Leaf Venture Partners, L.L.C. | 335,000 | $365,150 | 0.47% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,973,683 | $2,151,314 | 0.25% |
| Monashee Investment Management LLC | 427,265 | $465,719 | 0.20% |
| Orbimed Advisors | 7,133,515 | $7,775,531 | 0.16% |
| Parkman Healthcare Partners LLC | 800,000 | $872,000 | 0.16% |